SURWEY real-world study of solriamfetol: initiation, titration, safety, efficacy, and follow-up experience for patients with obstructive sleep apnea in Germany [PDF]
Purpose Solriamfetol is approved for use in the European Union to treat excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA). SURWEY characterized real-world evidence regarding physician initiation and titration strategies
Benes, Heike +6 more
core +1 more source
Central sleep apneas with Cheyne-Stokes breathing in a patient with narcolepsy type 1. [PDF]
, 2023 De Pieri, M +3 more
core +1 more source
Sleep Disorder and its Treatment: From Nature to Laboratory [PDF]
Sleep is the natural cellular repair mechanism to improve and restore central neural mechanism, memory, hormonal imbalance, and finally, cell rejuvenation.
Jakhmola, Vikash +3 more
core +2 more sources
EClinicalMedicineSummary: Background: Obstructive sleep apnoea (OSA) is a prevalent chronic condition that is associated with cardiometabolic and neurocognitive complications.
Camille Figard +7 more
doaj +1 more source
Histaminergic neuronal pathways underlie susceptibility and resilience to psychosocial stress [PDF]
, 2023 Blandina, P. +4 more
core +1 more source
0613 Effects of Pitolisant on Nighttime Sleep [PDF]
Sleep, 2019 Ulf Kallweit, Annika Triller
openaire +1 more source
Treatment paradigms for cataplexy in narcolepsy: past, present, and future
Nature and Science of Sleep, 2015 Todd J Swick1–4 1Department of Neurology, University of Texas School of Medicine-Houston, Houston; 2The Sleep Center at North Cypress Medical Center, Cypress; 3Apnix Sleep Diagnostics, Houston; 4Neurology and Sleep Medicine Consultants, Houston, TX,
Swick TJ
doaj
The histamine H_3 receptor inverse agonist pitolisant reduces body weight in obese mice [PDF]
, 2018 Kieć-Kononowicz, Katarzyna +4 more
core +1 more source
Pitolisant for the treatment of cataplexy in adults with narcolepsy [PDF]
Expert Opinion on Orphan Drugs, 2021 Gerard J. Meskill +6 more
openaire +1 more source
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Drug Design, Development and Therapy, 2016 Bassem Sadek,1 Ali Saad,1 Johannes Stephan Schwed,2,3 Lilia Weizel,2 Miriam Walter,2 Holger Stark2,3 1Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates ...
Sadek B +5 more
doaj